Tag: Novartis
-
Possible Beovu Side Effects Discussed At American Society of Retina Specialists Annual Meeting In July 2020
Current Findings On Risks Of Occlusive Vasculitis And Vision Loss Following Beovu Injections For Treatment Of Wet AMD (Posted by Tom Lamb at DrugInjuryWatch.com) According to news reports, Beovu safety issues were…
-
Beovu Safety Signal Found By External Review Committee Which Evaluated Beovu Post-Marketing Adverse Events
New Vision-Related Side Effects Warnings For Beovu Eye Injections Have Been Added In US, Australia, And Switzerland, Thus Far (Posted by Tom Lamb at DrugInjuryWatch.com) In this recent article, “Beovu Label Change:…
-
Beovu Label Change: Warnings About Possible Permanent Vision-Loss Side Effects Added In June 2020
Beovu Use Increased Risks Of Retinal Vasculitis And Retinal Vascular Occlusion, Which Can Lead To Blindness (Posted by Tom Lamb at DrugInjuryWatch.com) In early June 2020, the FDA approved a label update…
-
Beovu Vision-Related Side Effects Warnings Label Change Request By Novartis: News Report
This Is A Reversal Of March 2020 Novartis Position That Current Beovu Drug Label Provided Sufficient Warnings (Posted by Tom Lamb at DrugInjuryWatch.com) According to an April 2020 news report, Novartis has…
-
Novartis Contends Beovu Safety Should Not Be In Dispute As Current Drug Label Provides Sufficient Warnings
At Issue Is Dangerous Form Of Eye Inflammation, Occlusive Retinal Vasculitis, Which Can Lead To Vision Loss Or Blindness (Posted by Tom Lamb at DrugInjuryWatch.com) On March 2, 2020 Novartis stated that…
-
Beovu Side Effects Include Retinal Vasculitis, Eye Inflammation: Safety Issues For Macular Degeneration Drug
News Reports: There Have Been 11 Cases Of Beovu-Associated Occlusive Retinal Vasculitis, Which Can Lead To Blindness (Posted by Tom Lamb at DrugInjuryWatch.com) Several late February 2020 news articles report that the…
-
Gilenya Birth Defects Warnings Issued By Drug Safety Regulators In Canada And Europe — But Not By FDA In The US
Gilenya Increased Risk of Major Congenital Malformations Such As Renal / Kidney And Musculoskeletal Abnormalities, Atrial Septal Defects (Posted by Tom Lamb at DrugInjuryWatch.com) On December 19, 2019 Health Canada issued a…
-
Tasigna Side Effects Include Ischemic Cerebrovascular Events, Ischemic Heart Disease, And Peripheral Arterial Occlusive Disease
Less Warning About These Atherosclerosis-Related Diseases By Novartis In The US, It Seems, Compared To What Has Been Done By The Drug Company In Canada (Posted by Tom Lamb at DrugInjuryWatch.com) Tasigna…
-
New Heart Failure Drug Entresto Apparently Has Safety Signal For Hypotension (Low Blood Pressure) Side Effect
Will Recent ISMP QuarterWatch Report Prompt FDA Regulatory Action, Including Possible Drug Label Change By Novartis? (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA approved Entresto™ (sacubitril and valsartan) tablets in July…